America May 1, 2024
J&J to resolve most cancer talc claims for $6.5B
Johnson & Johnson has introduced a significant proposal: a $6.5 billion plan to resolve ovarian cancer claims against its talc-based…
America May 1, 2024
Johnson & Johnson has introduced a significant proposal: a $6.5 billion plan to resolve ovarian cancer claims against its talc-based…
By Rihem Akkouche